data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=

Unlocking the Power of Next Generation Medicines with Targeted Delivery

Unlocking the Power of Next Generation Medicines with Targeted Delivery

What We Do

Beginning with neurological diseases we are leveraging the unique properties of milk exosomes for targeted therapeutics delivery

Solving the delivery problem for next generation therapies

Oral Bioavailability

Blood Brain Barrier Penetration

Programmable Tissue Targeting

Programmable Tissue Targeting

Blood Brain Barrier Penetration

Programmable Tissue Targeting

Blood Brain Barrier Penetration

Blood Brain Barrier Penetration

Blood Brain Barrier Penetration

Low Immunogenic Potential

DNA, RNA, Peptide & Drug Payloads

Blood Brain Barrier Penetration

DNA, RNA, Peptide & Drug Payloads

DNA, RNA, Peptide & Drug Payloads

DNA, RNA, Peptide & Drug Payloads

About Us

Janos Zempleni,PhD Cofounder & CSO

Janos Zempleni,PhD Cofounder & CSO

Janos Zempleni,PhD Cofounder & CSO


Pioneering expert in milk exosomes


William Cather Professor of Molecular Nutrition at University of Nebraska

Jiantao Guo,PhD Cofounder & VP of Biological Chemistry

Janos Zempleni,PhD Cofounder & CSO

Janos Zempleni,PhD Cofounder & CSO


Expert in bio-organic chemistry, chemical synthetic biology


Professor Dept of Chemistry at University of Nebraska

“At Minovacca, we are pioneering a platform technology to transform lives, delivering next-generation therapies to meet the world’s medical challenges.".

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Minovacca

Hours

Mon

09:00 am – 05:00 pm

Tue

09:00 am – 05:00 pm

Wed

09:00 am – 05:00 pm

Thu

09:00 am – 05:00 pm

Fri

09:00 am – 05:00 pm

Sat

Closed

Sun

Closed

Copyright © 2025 Minovacca - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept